The Complex Interplay Between Cholesterol and Prostate Malignancy

被引：62
作者：
Solomon, Keith R. [1 ]
Freeman, Michael R. [2 ,3 ]
机构：
[1] Harvard Univ, Sch Med, Childrens Hosp Boston,Dept Orthopaed Surg, Enders Res Labs,Urol Dis Res Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp Boston, Enders Res Labs,Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2011年 / 38卷 / 03期
关键词：
Prostate cancer; Cholesterol; Statins; Steroidogenesis; Castration resistance; CORONARY-HEART-DISEASE; ANDROGEN DEPRIVATION THERAPY; SCANDINAVIAN SIMVASTATIN SURVIVAL; RENAL-TRANSPLANT RECIPIENTS; TOTAL SERUM-CHOLESTEROL; INTIMA-MEDIA THICKNESS; LOW BLOOD CHOLESTEROL; 10-YEAR FOLLOW-UP; I CLINICAL-TRIAL; CANCER-MORTALITY;
D O I：
10.1016/j.ucl.2011.04.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Research into the role of cholesterol and prostate disease has been ongoing for many years, but our mechanistic and translational understanding is still poor. Recent evidence indicates that cholesterol-lowering drugs reduce the risk of aggressive prostate cancer. This article reviews the literature on the relationship between circulating cholesterol and prostate cancer. The data strongly point to hypercholesterolemia as a risk factor for prostate cancer progression and suggest clinical opportunities for the use of cholesterol-lowering therapies to alter disease course.
引用
收藏
页码：243 / +
页数：18
相关论文
共 188 条
[1]   Cholesterol sensitivity of endogenous and myristoylated Akt [J].
Adam, Rosalyn M. ;
Mukhopadhyay, Nishit K. ;
Kim, Jayoung ;
Di Vizio, Dolores ;
Cinar, Bekir ;
Boucher, Kelly ;
Solomon, Keith R. ;
Freeman, Michael R. .
CANCER RESEARCH, 2007, 67 (13) :6238-6246
[2]   Inhibition of acyl-coenzyme A:cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes [J].
An, Sojin ;
Jang, Young-Soon ;
Park, Ji-Seon ;
Kwon, Byoung-Mog ;
Paik, Young-Ki ;
Jeong, Tae-Sook .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2008, 40 (04) :407-417
[3]   CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY [J].
ANDERSON, KM ;
CASTELLI, WP ;
LEVY, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16) :2176-2180
[4]   CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer [J].
Ang, Je ;
Olmos, D. ;
de Bono, J. S. .
BRITISH JOURNAL OF CANCER, 2009, 100 (05) :671-675
[5]  
[Anonymous], 2000, Ital Heart J, V1, P810
[6]  
[Anonymous], 1993, Am J Cardiol, V72, P1031
[7]  
[Anonymous], J CLIN ONCOL S7
[8]   Is abiraterone acetate well tolerated and effective in the treatment of castration-resistant prostate cancer? [J].
Antonarakis, Emmanuel S. ;
Eisenberger, Mario A. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (01) :12-13
[9]   The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] [J].
Armitage, Jane ;
Collins, Rory ;
Bowman, Louise ;
Parish, Sarah ;
Sleight, Peter ;
Peto, Richard ;
Meade, T. ;
Youngman, L. ;
Buxton, M. ;
de Bono, D. ;
George, C. ;
Fuller, J. ;
Keech, A. ;
Mansfield, A. ;
Pentecost, B. ;
Simpson, D. ;
Warlow, C. ;
McNamara, J. ;
O'Toole, L. ;
Doll, R. ;
Wilhelmsen, L. ;
Fox, K. M. ;
Hill, C. ;
Sandercock, P. .
BMC MEDICINE, 2005, 3 (1)
[10]   Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven [J].
Attard, Gerhardt ;
Reid, Alison H. M. ;
Yap, Timothy A. ;
Raynaud, Florence ;
Dowsett, Mitch ;
Settatree, Sarah ;
Barrett, Mary ;
Parker, Christopher ;
Martins, Vanessa ;
Folkerd, Elizabeth ;
Clark, Jeremy ;
Cooper, Colin S. ;
Kaye, Stan B. ;
Dearnaley, David ;
Lee, Gloria ;
de Bono, Johann S. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) :4563-4571
12345678910